Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment

Press/Media: Expert Comment

Period	Nov 3 2021

Media coverage

Title	Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment
Media name/outlet	Venture Capital Firms
Country/Territory	Canada
Date	11/3/21
URL	https://www.vcaonline.com/news/news.asp?ID=2021110302
Persons	Rong Li